261 related articles for article (PubMed ID: 7542638)
1. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated.
Ingalls RR; Rice PA; Qureshi N; Takayama K; Lin JS; Golenbock DT
Infect Immun; 1995 Aug; 63(8):3125-30. PubMed ID: 7542638
[TBL] [Abstract][Full Text] [Related]
2. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14.
Bas S; Neff L; Vuillet M; Spenato U; Seya T; Matsumoto M; Gabay C
J Immunol; 2008 Jan; 180(2):1158-68. PubMed ID: 18178856
[TBL] [Abstract][Full Text] [Related]
3. Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC.
Heine H; Müller-Loennies S; Brade L; Lindner B; Brade H
Eur J Biochem; 2003 Feb; 270(3):440-50. PubMed ID: 12542694
[TBL] [Abstract][Full Text] [Related]
4. Chlamydia trachomatis Lipopolysaccharide Evades the Canonical and Noncanonical Inflammatory Pathways To Subvert Innate Immunity.
Yang C; Briones M; Chiou J; Lei L; Patton MJ; Ma L; McClarty G; Caldwell HD
mBio; 2019 Apr; 10(2):. PubMed ID: 31015326
[No Abstract] [Full Text] [Related]
5. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.
Lynn WA; Raetz CR; Qureshi N; Golenbock DT
J Immunol; 1991 Nov; 147(9):3072-9. PubMed ID: 1717586
[TBL] [Abstract][Full Text] [Related]
6. CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity.
Delude RL; Fenton MJ; Savedra R; Perera PY; Vogel SN; Thieringer R; Golenbock DT
J Biol Chem; 1994 Sep; 269(35):22253-60. PubMed ID: 7520914
[TBL] [Abstract][Full Text] [Related]
7. The Gram-negative bacterium Chlamydia trachomatis L2 stimulates tumor necrosis factor secretion by innate immune cells independently of its endotoxin.
Prebeck S; Brade H; Kirschning CJ; da Costa CP; Dürr S; Wagner H; Miethke T
Microbes Infect; 2003 May; 5(6):463-70. PubMed ID: 12758273
[TBL] [Abstract][Full Text] [Related]
8. Is lipopolysaccharide a factor in infectivity of Chlamydia trachomatis?
Fadel S; Eley A
J Med Microbiol; 2008 Mar; 57(Pt 3):261-266. PubMed ID: 18287286
[TBL] [Abstract][Full Text] [Related]
9. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
[TBL] [Abstract][Full Text] [Related]
10. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.
Kirikae F; Kirikae T; Qureshi N; Takayama K; Morrison DC; Nakano M
Infect Immun; 1995 Feb; 63(2):486-97. PubMed ID: 7529746
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
Kitchens RL; Ulevitch RJ; Munford RS
J Exp Med; 1992 Aug; 176(2):485-94. PubMed ID: 1380063
[TBL] [Abstract][Full Text] [Related]
12. Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis.
Ossewaarde JM; de Vries A; van den Hoek JA; van Loon AM
J Clin Microbiol; 1994 Jun; 32(6):1419-26. PubMed ID: 7521355
[TBL] [Abstract][Full Text] [Related]
13. Antigenic properties of Chlamydia trachomatis lipopolysaccharide.
Brade L; Nurminen M; Mäkelä PH; Brade H
Infect Immun; 1985 May; 48(2):569-72. PubMed ID: 2580795
[TBL] [Abstract][Full Text] [Related]
14. Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis.
Dessus-Babus S; Darville TL; Cuozzo FP; Ferguson K; Wyrick PB
Infect Immun; 2002 Jun; 70(6):3234-48. PubMed ID: 12011019
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies against lipopolysaccharide of Chlamydia trachomatis with cross reactivity to human ApoB.
Petyaev IM; Zigangirova NA; Tsibezov VV; Ross A; Bashmakov YK
Hybridoma (Larchmt); 2011 Apr; 30(2):131-6. PubMed ID: 21529285
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide.
Caldwell HD; Hitchcock PJ
Infect Immun; 1984 May; 44(2):306-14. PubMed ID: 6425219
[TBL] [Abstract][Full Text] [Related]
17. Influence of CD14, LBP and BPI in the monocyte response to LPS of different polysaccharide chain length.
Jahr TG; Sundan A; Lichenstein HS; Espevik T
Scand J Immunol; 1995 Jul; 42(1):119-27. PubMed ID: 7543211
[TBL] [Abstract][Full Text] [Related]
18. Activation of neutrophils by Chlamydia trachomatis-infected epithelial cells is modulated by the chlamydial plasmid.
Lehr S; Vier J; Häcker G; Kirschnek S
Microbes Infect; 2018 May; 20(5):284-292. PubMed ID: 29499390
[TBL] [Abstract][Full Text] [Related]
19. Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity.
Vicetti Miguel RD; Harvey SA; LaFramboise WA; Reighard SD; Matthews DB; Cherpes TL
PLoS One; 2013; 8(3):e58565. PubMed ID: 23555586
[TBL] [Abstract][Full Text] [Related]
20. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.
Schumann RR; Rietschel ET; Loppnow H
Med Microbiol Immunol; 1994 Dec; 183(6):279-97. PubMed ID: 7541105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
